Development Density Sample Clauses

Development Density. The maximum density for the Property shall be as set forth in the Amended GDP. It is acknowledged that application of City development standards and criteria may serve to limit or prevent development of density upon the Property.
AutoNDA by SimpleDocs
Development Density. Minimum setbacks for buildings shall be fifty (50) feet from all street lines, thirty (30) feet from side property lines and thirty (30) feet from rear property lines. The front yard (50 foot setback) shall be maintained as a 75% landscaped area with only paved driveways and sidewalks allowed. Where possible, a minimum fifty (50) foot setback area with existing landscaping shall be maintained along Forge Parkway. For side and rear yards, fifteen (15) foot setback lines shall be maintained as landscaped areas with the exception of 25% of such area allowed for paved driveways and sidewalks. Minimum fifty (50) foot setback and landscaped areas (with existing vegetation to remain) shall be maintained for land abutting residentially zoned property.
Development Density. The maximum aggregate amount of development density permitted on the Land with respect to certain project types is as follows ("Total Permitted Density"): Office 750,000 square feet of Net Floor Area Retail 250,000 square feet of Net Floor Area Residential 1,730 living units Multi-Family Residential 900 living units The development of Multi-Family Residential units consumes Development Allocations in both the Residential and the Multi- Family Residential Use Categories, i.e., for each Multi-Family Residential unit developed on the Land, there must be a Development Allocation of one Residential unit and one Multi- Family Residential unit for the Multi-Family Residential unit being developed. For the purpose of Development Allocations, each residential duplex structure shall be treated as two single- family residential living units.
Development Density. It was general public consensus that the development density of the PDS sites should be as low as possible. - Over 1,500 standard letters were included in one submission from an owners representatives committee of a residential estate adjacent to the PDS2 against any form of development on PDS2 & 3, apart from urban park. Another subsequent submission from the Chairman of the same owners representatives committee indicated that from a previous questionnaire survey carried out by the committee, 990 units (about 4000 residents) had expressed the same view. A similar request was reflected from a survey conducted by the Office of Kowloon City District Councillor. - Amongst the submissions requesting a lower development density and building height for PDS2 and PDS3, there were suggestions that the building height should be compatible or lower than that of Whampoa Garden. - Some expressed that if there is development, the number of proposed hotel and residential building should be reduced. The buildings in PDS2 and PDS3 should not result in / cause / have such effect as a “wind-shield”. - There was a submission suggesting to impose a stepping down profile of both height and plot ratio to ensure a good urban form and to minimize the impacts of the future Xxxx Xxx bay reclamation developments on existing residents and the harbourfront; whilst another submission suggests that the building at PDS 1 could be the tallest, then PDS 3 and PDS2, given their relative impact on the ventilation and in respect of current design, and the width of the CDA should be reduced to align with the eastern boundary of PDS3, leaving the remaining area for public open space. - One submission suggested incorporating the PDS3 into PDS2 so that the built facilities including bus terminus and community facilities could be provided with better flexibility. A taller height could be considered for the buildings in PDS3. The 2 sites could be linked by an elevated walkway, and it should be designed and operated comprehensively.
Development Density. The first full paragraph of Section 6.1A of the Development Agreement is hereby deleted in its entirety and the following is substituted therefor:
Development Density. The maximum aggregate amount of development density permitted on the Land with respect to certain project types is as follows (“Total Permitted Density”): Office 750,000 square feet of Net Floor Area Retail 410,000 square feet of Net Floor Area Residential 1,334 living units Multi-Family Residential 504 living units”

Related to Development Density

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Design Development Phase INDICATE IN STATEMENT OF WORK “NOT APPLICABLE” IF SECTION IS NOT APPLICABLE 1.1.6.1. The ARCHITECT/ENGINEER shall prepare from the approved Schematic Design Studies, the Design Development Documents consisting of drawings (including at least architectural, landscaping, civil, structural, mechanical and electrical plans, building sections; and finish schedule), outline specifications following the Construction Specification Institute "CSI" Format and other necessary documents to fix and describe the size and character of the entire Project as to its site, structural, mechanical, and electrical systems, materials and other such essentials as may be appropriate, for and until approved by the State. 1.1.6.2. The ARCHITECT/ENGINEER shall conduct meetings with the State, Efficiency Vermont, and relevant members of the design team, to review the Design Development Documents for the purposes of furthering the energy efficiency objectives of the Project. 1.1.6.3. The ARCHITECT/ENGINEER shall prepare for the State a revised accounting of how the Project is responding to LEED criteria. 1.1.6.4. The ARCHITECT/ENGINEER shall submit to the State a revised Statement of Probable Construction Cost based thereon for and until approved by the State.

  • Development Within twenty (20) Working Days after the Commencement Date and in accordance with paragraphs 3.10 to 3.12 (Amendment and Revision), the Contractor will prepare and deliver to the Authority for approval the full and final Security Plan which will be based on the draft Security Plan set out in Appendix B.

  • Design Development An interim step in the design process. Design Development documents consist of plans, elevations, and other drawings and outline specifications. These documents will fix and illustrate the size and character of the entire project in its essentials as to kinds of materials, type of structure, grade elevations, sidewalks, utilities, roads, parking areas, mechanical and electrical systems, and such other work as may be required.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for [ * ] Product [ * ] in the Field [ * ]. Pfizer will [ * ] with respect to the Development or Regulatory Approval of Products under this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!